- ►ahajournals.org P Dandona, A Aljada, A Chaudhuri, P … - Circulation, 2005 - Am Heart Assoc The original description of the metabolic syndrome by Reaven 1 consisted of
obesity, insulin resistance, hypertension, impaired glucose tolerance or
diabetes, hyperinsulinemia and dyslipidemia characterized by elevated ... Cited by 388 - Related articles - All 7 versions
- ►nih.gov DJ Rader - Journal of Clinical Investigation, 2006 - Am Soc Clin Investig HDLs were first characterized by using ultracentrifugation of plasma to separate
lipoproteins of different densities. Several studies were published in the 1970s
reporting an inverse association between plasma HDL cholesterol (HDL-C) ... Cited by 140 - Related articles - BL Direct - All 9 versions
- ►oxfordjournals.org D Rothenbacher, H Brenner, W Marz, W … - European Heart Journal, 2005 - Eur Soc Cardiology Methods and results Three hundred and twelve patients aged 40–68 with
angiographically confirmed stable CHD and 476 age- and gender-matched controls
were included in this case–control study. Adiponectin serum ... Cited by 76 - Related articles - All 3 versions
T Mazzone, A Chait, J Plutzky - The Lancet, 2008 - Elsevier Individuals with type 2 diabetes mellitus have increased cardiovascular disease
risk compared with those without diabetes. Treatment of the residual risk, other
than blood pressure and LDL-cholesterol control, remains important as the ... Cited by 37 - Related articles - All 11 versions
D Lann, D LeRoith - Medical Clinics of North America, 2007 - Elsevier Classically, the metabolic syndrome is characterized as group of pathologies
including visceral obesity, hypertension, dyslipidemia, and impaired glucose
tolerance. It is now realized that insulin resistance plays a principal ... Cited by 26 - Related articles - All 25 versions
- ►nursing2008.com DJ Hausenloy, DM Yellon - British Medical Journal, 2008 - pmj.bmj.com The last 20 years have witnessed dramatic reductions in cardiovascular risk
using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") to
lower levels of low-density lipoprotein cholesterol (LDL-C). Using this ... Cited by 22 - Related articles - BL Direct - All 11 versions
A Proteomics - PROTEOMICS-Clinical Applications - interscience.wiley.com In this study, proteomic analysis was performed on the skin of C57BL/6J mice
with type 2 diabetes and compared to nondiabetic controls. To induce obesity and
subsequent diabetes, mice were placed on a high-fat diet for 16 wk. After ... Cited by 10 - Related articles - BL Direct - All 4 versions
GK Singh - Current Treatment Options in Cardiovascular Medicine, 2006 - Springer Metabolic syndrome is a constellation of interrelated risk factors of metabolic
origin that often accompany obesity and consist of atherogenic dyslipidemia,
elevated blood pressure, impaired glucose tolerance, a prothrombotic state, ... Cited by 9 - Related articles - BL Direct - All 3 versions
Y Kurosawa, A Taniguchi, T Okano - Tissue Engineering, 2005 - liebertonline.com T HE RE - CREATION OF FUNCTIONAL TISSUES AND ORGANS requires the discrete
interactions of several cell types. In particular, most organs typically consist
of different cell populations arranged in a sophisticated three-dimen- ... Cited by 9 - Related articles - BL Direct - All 3 versions
MJ Haas, MH Horani, NCW Wong, AD … - Metabolism, 2004 - Elsevier Insulin induces transcription of the hepatic apolipoprotein AI (apo AI) gene by
increasing Sp1 binding to the promoter. To determine the effect of fatty acids
on this process, HepG2 cells cotransfected with the plasmid pAI.474.CAT ... Cited by 8 - Related articles - All 9 versions
